Aclaris Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | 20.8% | -785.4% | -787.0% |
| FY2021 | 30.3% | -1,327.1% | -1,344.0% |
| FY2022 | 86.5% | -302.0% | -292.1% |
| FY2023 | 89.0% | -311.6% | -283.1% |
| FY2024 | 85.1% | -758.2% | -705.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | 20.8% | -785.4% | -787.0% |
| FY2021 | 30.3% | -1,327.1% | -1,344.0% |
| FY2022 | 86.5% | -302.0% | -292.1% |
| FY2023 | 89.0% | -311.6% | -283.1% |
| FY2024 | 85.1% | -758.2% | -705.5% |